Genesee Valley Trust Company Increased Altria Group (MO) Position; Bkd Wealth Advisors Has Increased By $522,828 Its Merck & Co (MRK) Position

June 28, 2018 - By Shannon Black

Merck & Co., Inc. (NYSE:MRK) Logo

Bkd Wealth Advisors Llc increased Merck & Co Inc (MRK) stake by 61.31% reported in 2018Q1 SEC filing. Bkd Wealth Advisors Llc acquired 9,682 shares as Merck & Co Inc (MRK)’s stock rose 5.40%. The Bkd Wealth Advisors Llc holds 25,475 shares with $1.39M value, up from 15,793 last quarter. Merck & Co Inc now has $161.10B valuation. The stock decreased 1.38% or $0.84 during the last trading session, reaching $59.88. About 10.45 million shares traded. Merck & Co., Inc. (NYSE:MRK) has declined 9.15% since June 28, 2017 and is downtrending. It has underperformed by 21.72% the S&P500. Some Historical MRK News: 18/04/2018 – blacq: Mylan seeks deal for German Merck’s consumer products unit: sources FRANKFURT/NEW YORK (Reuters) – Generic; 19/04/2018 – P&G Acquires The Consumer Health Business Of Merck KGaA, Darmstadt, Germany; 18/05/2018 – U.S. FDA – COMBINATION ARMS AND THE CHEMOTHERAPY ARMS OF BOTH STUDIES ALSO REMAIN OPEN; 16/04/2018 – Dynavax Reports Interim Data for SD-101 in Combination With KEYTRUDA(R) (pembrolizumab) in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck; 07/03/2018 – MERCK & CO. WILL PAY EISAI AN UPFRONT PAYMENT OF $300M; 09/04/2018 – Merck KGaA Receives Approval for Mavenclad Therapy in UAE; 16/05/2018 – New Data from Merck’s Leading Immuno-Oncology Clinical Development Program in Over 25 Tumor Types to Be Presented at 2018 ASCO; 26/04/2018 – Bristol-Myers 1Q Opdivo Revenue $1.51 Billion; 10/05/2018 – PHARMACEUTICALS : CITIGROUP SAYS PREFER BUY-RATED MERCK, BRISTOL-MYERS AND ELI LILLY IN THE US; 07/03/2018 – Eisai Co., Ltd. and Merck Enter Global Strategic Oncology Collaboration for LENVIMA® (lenvatinib mesylate)

Genesee Valley Trust Company increased Altria Group Inc (MO) stake by 116.96% reported in 2018Q1 SEC filing. Genesee Valley Trust Company acquired 7,882 shares as Altria Group Inc (MO)’s stock declined 14.98%. The Genesee Valley Trust Company holds 14,621 shares with $920,000 value, up from 6,739 last quarter. Altria Group Inc now has $106.07B valuation. The stock decreased 0.20% or $0.11 during the last trading session, reaching $55.99. About 7.19 million shares traded. Altria Group, Inc. (NYSE:MO) has declined 24.97% since June 28, 2017 and is downtrending. It has underperformed by 37.54% the S&P500. Some Historical MO News: 17/05/2018 – Altria Share-Repurchase Program to Be Completed by End of the Second Quarter in 201; 09/04/2018 – Fitch Sees Altria as Well-Positioned Through Its Licensing Agreement With Philip Morris; 26/04/2018 – Altria 1Q Smokeable Products Segment Rev $5.41B; 22/05/2018 – Altria Group, Inc. Announces New Structure to Accelerate Its Innovation Aspiration; 09/04/2018 – Fitch: Altria’s Strong Profitability Benefits From Consistent Pricing Power, Reduced Variable Costs; 15/05/2018 – Valinor Adds VICI Properties Inc., Exits Altria: 13F; 17/05/2018 – ALTRIA GROUP INC MO.N FY2018 SHR VIEW $4.00, REV VIEW $19.64 BLN — THOMSON REUTERS l/B/E/S; 12/04/2018 – Altria to Host Webcast of 2018 First-Quarter Results; 26/04/2018 – ALTRIA GROUP INC – EXPECTS 2018 FULL-YEAR ADJUSTED EFFECTIVE TAX RATE WILL BE IN A RANGE OF ABOUT 23% TO 24%; 29/05/2018 – Altria, Reynolds, Lorillard, and Philip Morris Ordered to Issue Corrective Statements on Nicotine Addiction; 22nd Century’s

Among 10 analysts covering Altria Group (NYSE:MO), 8 have Buy rating, 0 Sell and 2 Hold. Therefore 80% are positive. Altria Group has $85.0 highest and $63 lowest target. $74.30’s average target is 32.70% above currents $55.99 stock price. Altria Group had 14 analyst reports since January 4, 2018 according to SRatingsIntel. The firm has “Buy” rating given on Friday, January 19 by Jefferies. Stifel Nicolaus maintained it with “Buy” rating and $78.0 target in Wednesday, January 10 report. The firm has “Equal-Weight” rating by Morgan Stanley given on Friday, April 27. Cowen & Co maintained it with “Buy” rating and $79.0 target in Monday, January 8 report. The rating was maintained by Piper Jaffray with “Buy” on Thursday, February 1. RBC Capital Markets upgraded the stock to “Buy” rating in Monday, April 30 report. Morgan Stanley maintained Altria Group, Inc. (NYSE:MO) rating on Tuesday, June 26. Morgan Stanley has “Equal-Weight” rating and $63 target. Morgan Stanley maintained it with “Equal-Weight” rating and $70 target in Wednesday, April 18 report. The stock has “Overweight” rating by PiperJaffray on Friday, February 2. The stock of Altria Group, Inc. (NYSE:MO) earned “Buy” rating by Wells Fargo on Thursday, January 4.

Since February 7, 2018, it had 1 insider buy, and 4 insider sales for $1.52 million activity. The insider Dillard James E III sold 6,500 shares worth $410,313. On Monday, April 30 Newman Mark bought $300,334 worth of Altria Group, Inc. (NYSE:MO) or 5,345 shares. On Friday, March 2 Quigley Brian W. sold $216,154 worth of Altria Group, Inc. (NYSE:MO) or 3,464 shares. 14,953 shares valued at $995,734 were sold by Johnson Craig A. on Wednesday, February 7. Shares for $199,488 were sold by SURGNER W HILDEBRANDT JR.

More important recent Altria Group, Inc. (NYSE:MO) news were published by: Seekingalpha.com which released: “Smoking Hot Dividend Hike Coming From Altria” on June 22, 2018, also Fool.com published article titled: “Are These 4 Fears About Altria Group Overblown?”, Seekingalpha.com published: “Shares Of Altria Are A Buy” on June 11, 2018. More interesting news about Altria Group, Inc. (NYSE:MO) was released by: Fool.com and their article: “Altria’s Best Hope for a Bounce” with publication date: June 23, 2018.

Investors sentiment decreased to 0.73 in 2018 Q1. Its down 0.20, from 0.93 in 2017Q4. It is negative, as 88 investors sold MO shares while 562 reduced holdings. 100 funds opened positions while 372 raised stakes. 1.16 billion shares or 0.04% more from 1.16 billion shares in 2017Q4 were reported. 9,960 were reported by Capstone Ltd Limited Liability Company. Dupont Cap Mgmt reported 136,464 shares. Balyasny Asset Limited Liability Company invested in 0.04% or 144,076 shares. Prelude Cap Mgmt Llc invested in 12,005 shares. Bragg Financial Inc owns 13,064 shares or 0.12% of their US portfolio. Koshinski Asset Mgmt accumulated 11,041 shares. 41,861 are held by National Bank Of The Ozarks. Westpac stated it has 87,095 shares. Cordasco Financial Network has 32,717 shares. The Michigan-based Arcadia Investment Mi has invested 0.02% in Altria Group, Inc. (NYSE:MO). Moreover, Wade G W & Inc has 0.05% invested in Altria Group, Inc. (NYSE:MO) for 7,106 shares. Washington Trust Bank, Washington-based fund reported 117,132 shares. Cornercap Invest Counsel reported 65,145 shares or 0.58% of all its holdings. Whitnell reported 3,000 shares. Boyar Asset has 0.22% invested in Altria Group, Inc. (NYSE:MO).

More notable recent Merck & Co., Inc. (NYSE:MRK) news were published by: Streetinsider.com which released: “Merck (MRK) Announces Findings from WHO-led Study of Heat-Stable Carbetocin for Preventing Excessive Bleeding …” on June 27, 2018, also Forbes.com with their article: “Merck’s Alimentary & Metabolism Drug Sales Have Likely Peaked” published on June 27, 2018, Streetinsider.com published: “UPDATE: Merck (MRK), AstraZeneca (AZN) Report Positive Results from Phase 3 First-Line SOLO-1 Trial for Ovarian …” on June 27, 2018. More interesting news about Merck & Co., Inc. (NYSE:MRK) were released by: 247Wallst.com and their article: “Short Sellers Hike Bets in Major Pharma Stocks” published on June 27, 2018 as well as Businesswire.com‘s news article titled: “Merck to Hold Second-Quarter 2018 Sales and Earnings Conference Call on July 27” with publication date: June 27, 2018.

Investors sentiment increased to 1 in 2018 Q1. Its up 0.06, from 0.94 in 2017Q4. It is positive, as 72 investors sold MRK shares while 603 reduced holdings. 114 funds opened positions while 561 raised stakes. 1.91 billion shares or 1.08% less from 1.93 billion shares in 2017Q4 were reported. 27.83 million are owned by Wells Fargo & Company Mn. Cleararc Inc holds 0.5% in Merck & Co., Inc. (NYSE:MRK) or 61,422 shares. Kidder Stephen W holds 0.17% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 8,410 shares. Accredited holds 0.15% in Merck & Co., Inc. (NYSE:MRK) or 9,938 shares. Mountain Pacific Advisers Incorporated Id has invested 0.03% in Merck & Co., Inc. (NYSE:MRK). Ubs Asset Americas holds 0% or 9.14 million shares in its portfolio. Morgan Stanley owns 15.76 million shares. Northpointe Cap Ltd Liability Corporation accumulated 35,131 shares. Beddow Mgmt holds 96,699 shares. Utd Automobile Association holds 3.50 million shares. Trust Communication Of Oklahoma invested in 0% or 6,960 shares. Birmingham Capital Al reported 70,569 shares. Ancora Advsr Limited accumulated 37,046 shares or 0.09% of the stock. Gargoyle Advisor Limited Liability holds 1.04% or 46,539 shares. Boston Common Asset Mngmt Lc owns 187,535 shares.

Bkd Wealth Advisors Llc decreased United Parcel Service Inc (NYSE:UPS) stake by 3,001 shares to 2,798 valued at $293,000 in 2018Q1. It also reduced Vanguard Index Fds (VB) stake by 10,049 shares and now owns 9,550 shares. Vanguard Intl Equity Index F (VEU) was reduced too.

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart